Loading…
Prognostic Value of IMP3 and Its Role as an Epithelial-Mesenchymal Transition Promoter in Breast Carcinoma
Breast carcinoma is now the most common cancer in the world. In view of its high mortality, there is a need to identify new prognostic biomarkers. Both IMP3 and SLUG have been implicated in cancer metastasis. This was a retrospective study conducted on 60 breast carcinoma cases using tissue microarr...
Saved in:
Published in: | Indian journal of surgical oncology 2023-09, Vol.14 (3), p.659-667 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Breast carcinoma is now the most common cancer in the world. In view of its high mortality, there is a need to identify new prognostic biomarkers. Both IMP3 and SLUG have been implicated in cancer metastasis. This was a retrospective study conducted on 60 breast carcinoma cases using tissue microarrays. Demographic and clinicopathological details were recorded. Immunohistochemistry for IMP3 and SLUG was performed and evaluated in terms of percentage-cell-positivity and intensity of staining. A proforma was used to store data and was analyzed using SPSS v20. IMP3 positivity was found in 87% breast carcinoma cases and was significantly associated with tumor size (
p
= 0.03) and TNM stage (
p
= 0.024). IMP3 staining intensity showed significant association with histological grade (
p
= 0.009), TNM stage (
p
= 0.036), and molecular subtype (
p
= 0.03). SLUG immunoexpression was seen in 90% breast carcinoma cases and was significantly associated with TNM stage (
p
= 0.006). SLUG staining intensity was significantly associated with age (
p
= 0.025) and TNM stage (
p
= 0.004). IMP3 and SLUG immunopositivity and their staining intensities were significantly associated (
p |
---|---|
ISSN: | 0975-7651 0976-6952 |
DOI: | 10.1007/s13193-023-01735-7 |